Investor directoryFlerie
Flerie invests in and builds companies with pioneering pharmaceutical and biotech projects or adjacent capabilities.
What they invest in
Sectors
Geographies
global
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Stockholm, Sweden
- Founded
- 2011
More portfolio companies
A3P BiomedicalEgetis Therapeutics (STO: EGTX)Vitara BiomedicalEpiEndo PharmaceuticalsMicrobioticaProkariumSynerkine PharmaGeneos TherapeuticsAmarna TherapeuticsCobra BiologicsProvell PharmaceuticalsBuzzard PharmaceuticalsAtrogiEmpros PharmaKAHR BioAlder TherapeuticsXspray Pharma (STO: XSPRAY)Bonsai BiotherapeuticsBiosergenToleranziaNanologica (STO: NICA)Coriolis PharmaBohus (Other Devices and Supplies)Beactica Therapeutics
and 2 more
Questions founders ask
- How much does Flerie typically invest?
- Flerie states a typical cheque of €1M – €30M.
- Which stages does Flerie invest in?
- Flerie invests at Seed, Series A, Series B and Growth.
- Where is Flerie based?
- Flerie is headquartered in Stockholm, Sweden.
Search investors like this in Claude — no account, no sign-in. Open in Claude
Are you Flerie? Tell us what to correct and we will update it — or ask us to remove the entry.